FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology and can be used for prediction of left atrial thrombosis prior to catheter ablation or cardioversion. Gender, age, chronic heart failure, arterial hypertension, diabetes mellitus, history of stroke, vascular disease, persistent or long-term persistent forms of AFib/AFlu are detected. Calculated glomerular filtration rate (cGFR) is determined by formula CKD-EPI and LV EF. EHRA is used to assess severity of symptoms associated with AFib/AFlu. Each indicator is evaluated in points. If the total score is 8 and less, a low expected rate of thrombosis in the left atrium is predicted. If the total score is more than 8, a high expected rate of thrombosis in the left atrium is predicted.
EFFECT: method provides higher odds ratio of detecting left atrial thrombosis, higher sensitivity, specificity and predictive value of positive and negative results by assessing the complex of the most significant parameters.
1 cl, 1 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ASSESSING THE PROBABILITY OF LEFT ATRIAL APPENDAGE THROMBOSIS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | 2022 |
|
RU2798785C1 |
| METHOD FOR PREDICTING LEFT ATRIAL APPENDAGE THROMBOSIS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | 2021 |
|
RU2781152C1 |
| METHOD FOR DETERMINING THROMBOSIS OF LEFT ATRIAL APPENDAGE ACCORDING TO CONTRAST TRANSTHORACIC ECHOCARDIOGRAPHY | 2019 |
|
RU2723391C1 |
| METHOD FOR PERSONALIZING THE APPROACH TO INTERVENTIONAL TREATMENT OF ATRIAL FIBRILLATION | 2022 |
|
RU2791135C1 |
| METHOD FOR ASSESSING CLINICAL SIGNIFICANCE OF ATRIAL FIBRILLATION IN DETERMINING INDICATION FOR ATRIAL FIBRILLATION INTERVENTIONAL TREATMENT | 2022 |
|
RU2791191C1 |
| METHOD FOR CHOOSING THE METHOD FOR VISUALIZATION OF TRANSSEPTAL CATHETERIZATION OF THE LEFT ATRIUM | 2022 |
|
RU2791130C1 |
| METHOD FOR SURGICAL OBLITERATION OF LEFT ATRIAL APPENDAGE IN PATIENTS WITH ATRIAL FIBRILLATION IN OPERATION ON MITRAL VALVE OR MITRAL VALVE AND OPERATION "LABYRINTH" IN CONDITIONS OF ARTIFICIAL CIRCULATION | 2019 |
|
RU2691437C1 |
| METHOD FOR DETERMINING THE PROBABILITY OF CEREBRAL AND NON-CEREBRAL THROMBOEMBOLIA OF THE PULMONARY ARTERIES | 2018 |
|
RU2710213C1 |
| METHOD OF PREDICTION THE RECURRENCE OF FIBRILLATION OF PRECURITIES FOR REMOTE TIMES AFTER OPERATION OF RADIO FREQUENCY ABLATION OF PULMONARY VEIN ENTRANCES FOR PATIENTS WITH FRONT-REAR SIZE OF LEFT ATRIUM NOT MORE THAN 5 CM | 2017 |
|
RU2644939C1 |
| METHOD FOR MODELING STABLE ATRIAL FIBRILLATION IN ANIMALS (VARIANTS) | 2021 |
|
RU2760087C1 |
